Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double-blind randomized sham-controlled study

Autor: Choné, Adrien, Familiari, Pietro, von Rahden, Burkhard, Desai, Pankaj, Inoue, Haruhiro, Shimamura, Yuto, Eleftheriadis, Nikos, Yamashita, Kanefumi, Khashab, Mouen, Shiwaku, Hinorari, Seewald, Stefan, Draganov, Peter, Alvarez, Lybil, Chaussade, Stanislas, Tantau, Marcel, Abraham, Mathew, Marks, Jeffrey, Arevalo, Gabriel, Albéniz, Eduardo, Dubois, Rémi, Lachaux, Alain, Benech, Nicolas, Ponchon, Thierry, Barret, Maximilien, Mion, Francois, Marjoux, Sophie, Subtil, Fabien, Pioche, Mathieu, Rivory, Jérôme, Roman, Sabine, Zerbib, Frank

Publikováno v: Neurogastroenterology & Motility
Neurogastroenterology & Motility, 2019, 31 (5), pp.e13587. ⟨10.1111/nmo.13587⟩
Neurogastroenterology & Motility, Wiley, 2019, 31 (5), pp.e13587. ⟨10.1111/nmo.13587⟩

Introduction Botulinum toxin injection is known to be efficient to treat achalasia. We conducted a randomized trial in order to evaluate its efficacy to treat symptomatic hypercontractile esophageal disorders as characterized by esophageal high-resol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26fb21f0ed30e0055b8302b60a8eda23
https://pubmed.ncbi.nlm.nih.gov/30993816

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.